Gyno-PGx

Sale price $450.00 Regular price $500.00

Shipping calculated at checkout.

Pharmacogenomic Test for Drugs Related to Women’s Sexual Health

This PGx test uses a simple cheek swab to test a combination of genes related to the metabolism of drugs used in the management and treatment of female sexual health problems like pain during sexual intercourse, birth control, female hypoactive sexual desire disorder (HSDD), and pain associated with endometriosis.

If you are currently taking one of the following drugs, FDA recommends getting tested to determine if you have a gene mutation that could render a drug ineffective, cause unwanted side effects or result into a life-threatening event. Based on this information, your healthcare provider can suggest a different drug that can be safer and more effective. 

For further understanding, please refer to the United States FDA recommendations on Pharmacogenomic Biomarkers in Drug Labeling.

DRUG

GENE

Ospemifene (2)

CYP2B6

Drospirenone & Ethinyl Estradiol

CYP2C19

Flibanserin (2)

CYP2C19

Flibanserin (1)

CYP2C9

Ospemifene (1)

CYP2C9

Flibanserin (3)

CYP2D6

Elagolix

SLCO1B1